Overall, our study confirms that the application of the albumin-binding strategy is a relatively simple and effective method to improve the tumor-targeting potential of peptide-based radiopharmaceuticals labeled with long half-life 177Lu isotope. This evidence concerns the gene ALB and neoplasm.